Full-Time

Senior Manager

Medical Affairs, Surgical

Posted on 6/17/2025

Deadline 6/30/25
Alcon

Alcon

10,001+ employees

Specializes in eye care products and solutions

No salary listed

Senior

No H1B Sponsorship

Fort Worth, TX, USA

Relocation: Yes; Travel: 10% domestic

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s Degree or Equivalent years of directly related experience (or high school+15 yrs; Assoc.+11 yrs; M.S.+4 yrs; PhD+3 yrs)
  • The ability to fluently read, write, understand and communicate in English
  • 7 Years of Relevant Experience
Responsibilities
  • Support the execution of comprehensive Medical Affairs strategic plans
  • Support development of regional medical affairs strategy for the assigned therapeutic area
  • Provide medical and scientific support for product messaging and claims development
  • Support post market/phase IV studies strategy and preregistration study strategic input
  • Support launch strategies, life-cycle management and expansion of indications for use
  • Support medical publications: Develop content for whitepapers, peer-reviewed manuscripts, posters, scientific articles and video scripts
  • Support customer medical inquires (i.e. medical exchange of information with KOLs, and management of medical issues raised by customer Health Care providers)
  • Maintain peer-to-peer relationships with Medical Experts/Key Stakeholders and members of the scientific community, utilizing scientific and medical evidence-based non-promotional materials
  • Support planning and execution of medical advisory board meetings
  • Provide fair-balanced scientific and educational information to healthcare professionals on specific medical issues
  • Support internal training, and as needed for academic or healthcare professionals
  • Medical promotional review support as needed

Alcon specializes in eye care products and vision solutions aimed at improving people's eyesight and overall quality of life. Their product offerings include solutions for cataract surgery, retinal health, and contact lenses. Alcon's products work by utilizing advanced technology and research to provide effective treatments and aids for various eye conditions. What sets Alcon apart from its competitors is its strong emphasis on research and development, ensuring that they remain leaders in the eye care industry. Additionally, Alcon is dedicated to fostering a diverse and inclusive workplace, which is reflected in their corporate culture. The company's goal is to enhance vision and eye health for individuals worldwide while maintaining a commitment to innovation and inclusivity.

Company Size

10,001+

Company Stage

IPO

Headquarters

Geneva, Switzerland

Founded

1945

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for minimally invasive surgeries boosts Alcon's surgical product line.
  • Global myopia increase drives demand for Alcon's corrective lenses.
  • Telemedicine rise offers new distribution channels for Alcon's eye care products.

What critics are saying

  • Emerging startups with advanced tech pose competition to Alcon's market share.
  • Patent litigation, like Alcon Inc. v. Padagis, risks financial setbacks.
  • Regulatory challenges may delay Alcon's acoltremon ophthalmic solution launch in the US.

What makes Alcon unique

  • Alcon leads in eye care with innovative cataract and retinal health solutions.
  • Their commitment to diversity and inclusion strengthens their corporate culture and market appeal.
  • Alcon's focus on R&D ensures they remain at the forefront of eye care innovation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision coverage

HSA Medical Plan

PTO

Paid Parental leave

401k

Retirement Plan Company Contribution

Low payroll deductions

Tuition Reimbursement Program

Annual Bonus

Free Family Contact Lens Program

12 Company Paid Holidays

Company News

HCPLive
May 29th, 2025
FDA Approves Acoltremon Ophthalmic Solution (TRYPTYR) for Dry Eye Disease

Alcon has also announced its intention to launch acoltremon ophthalmic solution in the US during the third quarter of 2025 and anticipates bringing it to other markets in the future.

Alcon
May 1st, 2025
Alcon Showcases and Supports Innovators and Entrepreneurs at the ARVO 2025 Eye Pitch Live Event

Alcon showcases and supports innovators and entrepreneurs at the ARVO 2025 Eye Pitch live event.

Clival
Apr 30th, 2025
Alcon introduces PRECISION1 contact lenses in India with a new launch campaign

Alcon introduces PRECISION1 contact lenses in India with a new launch campaign.

JD Supra
Apr 29th, 2025
Alcon Inc. v. Padagis Israel Pharms. Ltd.

Case name: Alcon inc. v. Padagis israel pharms.

Alcon
Apr 10th, 2025
Alcon Celebrates 110 Years of Swiss Precision and Innovation in Ophthalmic Microsurgery

Alcon acquired Grieshaber in 2000, recognizing its longstanding expertise in precision ophthalmic microsurgery.